Applied DNA Sciences

Innovation in the Age of Coronavirus

The COVID-19 pandemic and its evolving aftermath are reshaping the world around us, and myriad Long Island forces – large and small, corporate and nonprofit, industrial and academic – have risen to the challenge. Innovate Long Island presents Innovation in the Age of Coronavirus as a real-time journal of this region’s resourceful response to the greatest global challenge since World War II. Stay healthy, dear readers.   Comptroller: The coronavirus ate my economic progress (July…


Applied DNA ups ante, again, with Clinical Labs spinoff

By GREGORY ZELLER // One of Long Island’s busiest biotechs has spun off another local startup, this time focused on testing its own potential breakthroughs. Stony Brook-based Applied DNA Sciences, which has quickly evolved from an upstart DNA-based supply-chain authenticator to a leader in unique DNA manufacturing, has launched Applied DNA Clinical Labs LLC, a wholly owned subsidiary dedicated to the commercial development of two key verticals: Applied DNA’s virology tests, designed to quickly detect…


Orbit degrades, but CEO says boosters will right ship

  ORBIT INTERNATIONAL CORP. Headquarters: Hauppauge Industry: Capital goods OTC: ORBT Reporting Date: June 12, 2020 Reporting Quarter: 1Q FY2020 Quarter Ended: March 31, 2020 Numbers: Reported first-quarter net sales were $5.85 million, a 9.8-percent drop from the $6.49 million reported for the same quarter last fiscal year. Quarterly net income nosedived year-over-year – down more than 71 percent, to $20,000 – and earnings followed: First-quarter EBITDA was reported as $86,000 (2 cents per diluted…


No. 509: On peanut butter cookies, LaGuardia Airport and kelp – plus baseball (remember that?)

  Phase 2 Friday: You’ve done it again, dear readers! Another tough workweek conquered – and, as your reward, Long Island’s first weekend under Phase 2 reopening protocols. Well played! It’s June 12 out there, and while you’re probably itching for your teenager to find a summer job after a half-year of home learning, it is indeed the U.N.’s World Day Against Child Labour, which is a very different matter and no joke. That’s, like,…


No. 498: On crepes, mosques and tough love – and Long Island, home of the COVID-19 vaccine?

  Schastlivaya pandemiya: Over the homebound hump we go, dear comrades, as we brave another week of the great 2020 pandemic – and, even scarier, another week locked up with those we love most. To that end, these sanity-maintenance tips from the Russian Health Ministry. You’re welcome. Crepes us out: Now here’s a dangerous combo – May 6 is both National Crepe Suzette Day, celebrating the caramelized dessert, and National No Diet Day, which, let’s…


Gains on two fronts: Same-day test, virus ‘neutralizer’

By GREGORY ZELLER // An ambitious Long Island biotech is reporting exciting progress in a two-front battle against the raging novel coronavirus. Stony Brook-based Applied DNA Sciences on Tuesday announced that it has applied for FDA approval of its Linea COVID-19 diagnostic kit, which detects SARS-CoV-2 – the novel coronavirus that causes the COVID-19 disease – with same-day results. The announcement comes one day after Applied DNA and Italian biopharma Takis Biotech said the first…


No. 493: On foundations, fellows, foreign tongues – and redemption for your pandemic pantry

  Gives us pause: It’s Friday again, dear readers, and while there’s no end in sight to the great 2020 pandemic, the same can’t be said for this latest work-from-home week of socioeconomic innovation. On blood, and bloodsuckers: It’s April 17 out there – World Hemophilia Day, when bleeding disorders take center stage, and International Bat Appreciation Day, when we give the flying rodents – which are largely insectivores and great pollinators, and almost never…


LI biotech speeds COVID-19 vaccine candidates to Italy

By GREGORY ZELLER // With preliminary lab tests looking good, an innovative Long Island biotech is rushing a quintet of potential COVID-19 vaccines overseas. Stony Brook-based Applied DNA Sciences announced Wednesday that it has completed “design qualifications” and shipped five COVID-19 vaccine candidates to Italian biopharma Takis Biotech, a frequent collaborator working closely with Applied DNA to counter the coronavirus. The vaccine candidates were produced using the Stony Brook biotech’s proprietary, polymerase chain reaction-based LinearDNA…


No. 486: On mega-moons, linear DNA and innovative immigrant services – and yes, lots of coronavirus stuff

  The unusual: Welcome to Wednesday, dear readers, and the midpoint of another weird and wild workweek, as the Great Coronavirus Pandemic continues to reshape our world and the regional and global innovation economies scramble to keep up. Please celebrate alone: It’s March 25 out there, the U.N.’s International Day of Solidarity With Missing or Detained Staff Members, which is actually about U.N. employees who made the ultimate sacrifice, but seems oddly redefined today. To…


No. 481: In which aspirin arrives, coronavirus hits home and microbes pig out

  Week strain: It’s been a stressful five days, dear readers, with the crashing stock markets and global pandemics, but you’ve persevered again – another Friday reached, another weekend on tap. Well done. It’s March 6 out there, and a fairly busy day on Planet Earth: Independence Day in Ghana, Foundation Day across the Norfolk Islands and Europe’s Day of the Righteous, honoring those who choose a moral path. Culture clash: Here in the States,…


No. 480: On coronavirus, coronavirus and coronavirus – and introducing our 2020 Master of Innovation

  Don’t worry, we washed our hands: Put ’er there, dear readers, and welcome to Wednesday, as we hurtle the hump of this latest busy (and blessedly spring-like) winter workweek. It’s March 4 out there – St. Casimir’s Day, honoring the patron saint of Poland and Lithuania, and National Pound Cake Day, celebrating the world’s most versatile cake. Strong language: It’s also National Grammar Day, a celebration of proper written and verbal grammar, desperately needed…


Island firm speeds coronavirus vaccines toward tests

By GREGORY ZELLER // Just weeks after announcing an expanded international collaboration targeting the menacing novel coronavirus, Applied DNA Sciences is preparing to mass-produce four potential vaccines. Leveraging the Stony Brook-based biotech’s unique DNA-manufacturing abilities, Rome, Italy-based Takis Biotech will test potential vaccines against the coronavirus (now going by COVID-19) in laboratory mice, on a large scale. Applied DNA expects delivery of four DNA-based “preclinical vaccine candidates” from Takis this month, and “within weeks” will…


No. 477: In which the Suffolk IDA incentivizes and the double helix debuts – plus, sticky buns for all!

  Just a word or two: Welcome to Friday, dear readers, as we wrap up another busy workweek and look forward to another well-earned weekend. It’s Feb. 21 out there, and before we begin, please speak up – today is International Mother Language Day, the U.N.’s multicultural salute to linguistic diversity. Going to extremes: Today is also National Grain-Free Day (a big one for the low-carb set) and National Sticky Buns Day (not so much)….


No. 475: Love is in the air – along with Ferris wheels, podcasts and ‘mega sports’

  We heart you: You’ve done it again, dear reader – another workweek conquered, another Friday reached, and for that, you have our undying affection. It’s Feb. 14 out there, which in addition to Valentine’s Day brings several annual celebrations: National Cream-Filled Chocolates Day (makes sense), National Condom Day (ditto) and Frederick Douglass Day (which you might not have thought of, but the famed abolitionist’s actual birthdate is unknown and he chose Feb. 14, so…


Applied DNA to speed up coronavirus countermeasures

By GREGORY ZELLER // Look out, coronavirus – Applied DNA is coming for you. Adding to its growing portfolio of cutting-edge Polymerase Chain Reaction-based projects, Stony Brook-based Applied DNA Sciences is expanding its Joint Development Agreement with Italian R&D company Takis Biotech, with the headline-making 2019-nCoV in their sights. Already hot on the trail of new cancer vaccines, the partners will now work on a “linear DNA” vaccine against the dreaded Wuhan, China-based illness that’s…